Efficacy and Safety of Carfilzomib, Dexamethasone, Daratumumab (KdD) Twice-Weekly at 56 mg/m(2) and Once-Weekly at 70 mg/m(2) in Relapsed or Refractory Multiple Myeloma (RRMM): Cross-Study Comparison of the CANDOR and EQUULEUS studies

Authors :: Leleu, X
Beksac, M
Chou, T
Dimopoulos, M
Yoon, SS
Prince, HM
Pour, L
Shelekhova, T
Chari, A
Khurana, M
Obreja, M
Qi, M
Oriol, A
Siegel, D
Source :: Clinical Lymphoma Myeloma & Leukemia, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname
Publication Year :: 2020
Publisher :: Cancer Media Group, 2020.

Subjects :: multiple myeloma
carfilzomib
weekly dosing
KdD
MM
cross-study comparison

ISSN :: 21522650
Database :: OpenAIRE
Journal :: Clinical Lymphoma Myeloma & Leukemia, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname
Accession number :: edsair.RECOLECTA.....e5bd6bead6f5a4f626751e7cb473466e

Tools